Jason M Shohet

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 4

Top Topics

Advanced Non Small Cell Lung Cancer

Tyrosine Kinase

Top Venues

Molecular cancer therapeutics

Nature communications

Pediatric blood & cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Esteban Javier Rozen, William Tyler Frantz, Kim Wigglesworth, Theadora Vessella, Hong Susan Zhou, Jason M Shohet
Blockade of Discoidin Domain Receptor Signaling with Sitravatinib Reveals DDR2 as a Mediator of Neuroblastoma Pathogenesis and Metastasis. Molecular cancer therapeutics (2024)
Esteban Javier Rozen, William Tyler Frantz, Kim Wigglesworth, Theadora Vessella, Hong Susan Zhou, Jason M Shohet
Blockade of Discoidin Domain Receptor Signaling with Sitravatinib Reveals DDR2 as a Mediator of Neuroblastoma Pathogenesis and Metastasis. Molecular cancer therapeutics 23 (8) (2024)
Lei Huang, Xiao-Ou Zhang, Esteban J Rozen, Xiaomei Sun, Benjamin Sallis, Odette Verdejo-Torres, Kim Wigglesworth, Daniel Moon, Tingting Huang, John P Cavaretta, Gang Wang, Lei Zhang, Jason M Shohet, Mary M Lee, Qiong Wu
PRMT5 activates AKT via methylation to promote tumor metastasis. Nature communications 13 (1) (2022)
Sarah B Whittle, Valeria Smith, Allison Silverstein, Margaret Parmeter, Charles G Minard, Melanie Brooke Bernhardt, Peter E Zage, Rajkumar Venkatramani, Jed G Nuchtern, Andras Heczey, Heidi V Russell, Jason M Shohet, Jennifer H Foster
Is high-risk neuroblastoma induction chemotherapy possible without G-CSF? A pilot study of safety and treatment delays in the absence of primary prophylactic hematopoietic growth factors. Pediatric blood & cancer 67 (10) (2020)